NSE filing, NSE: TTKPRESTIG. Summary written from the filing by ALFA Finder's alert engine.
TTK Prestige Ltd: key numbers
- Share price
- ₹532.50
- Market cap
- ₹7,294 Cr
- Revenue (annual)
- ₹2,974 Cr
- Net profit (annual)
- ₹160.6 Cr
- P/E (TTM)
- 42.7×Sector 41.7×
- Promoter holding
- 70.51%-0.01% QoQ
- FII holding
- 7.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TTK Prestige Ltd
All →TTK Prestige Business Update
TTK Prestige redeemed its entire CCD investment in GramyaHaat Rural-Tech made in June 2024. The redemption resulted in a non-material loss with no impact on financial position.
TTK Prestige Other Announcement
TTK Prestige Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
TTK Prestige Merger & Restructuring
TTK Prestige has completed the sale of its 51% stake in subsidiary Ultrafresh Modular Solutions to EFC (I) Limited. Ultrafresh ceases to be a subsidiary.
TTK Prestige Board Meeting Date
TTK Prestige will hold a board meeting on November 06, 2026, to approve its financial results for the quarter ended September 30, 2026.
TTK Prestige Management Change
TTK Prestige appointed Mr. R Srinivasan as Non-Executive Non-Independent Director effective 10 September 2026. He was reappointed following retirement by rotation at the 70th AGM, approved via postal ballot.
TTK Prestige Annual General Meeting
TTK Prestige shareholders passed a postal ballot appointing Mr. R. Srinivasan as Non-Executive Non-Independent Director. Resolution secured 99.97% favourable votes on September 10, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date